Summary
GlobalData's Medical Devices sector report, “Traditional Glucose Meters - Medical Devices Pipeline Assessment, 2017" provides an overview of Traditional Glucose Meters currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Traditional Glucose Meters pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type
Scope
- Extensive coverage of the Traditional Glucose Meters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Traditional Glucose Meters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Traditional Glucose Meters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Companies Mentioned
Integrity Applications Ltd
IntelliDx Inc
Intuity Medical Inc
LifeScan Inc
LighTouch Medical, Inc.
POPS! Diabetes Care Inc
'
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 Traditional Glucose Meters Overview 5
3 Products under Development 6
3.1 Traditional Glucose Meters - Pipeline Products by Stage of Development 6
3.2 Traditional Glucose Meters - Pipeline Products by Territory 7
3.3 Traditional Glucose Meters - Pipeline Products by Regulatory Path 8
3.4 Traditional Glucose Meters - Pipeline Products by Estimated Approval Date 9
3.5 Traditional Glucose Meters - Ongoing Clinical Trials 10
4 Traditional Glucose Meters - Pipeline Products under Development by Companies 11
4.1 Traditional Glucose Meters Companies - Pipeline Products by Stage of Development 11
4.2 Traditional Glucose Meters - Pipeline Products by Stage of Development 12
5 Traditional Glucose Meters Companies and Product Overview 13
5.1 Integrity Applications Ltd Company Overview 13
5.1.1 Integrity Applications Ltd Pipeline Products & Ongoing Clinical Trials Overview 13
5.2 IntelliDx Inc Company Overview 16
5.2.1 IntelliDx Inc Pipeline Products & Ongoing Clinical Trials Overview 16
5.3 Intuity Medical Inc Company Overview 17
5.3.1 Intuity Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 17
5.4 LifeScan Inc Company Overview 18
5.4.1 LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview 18
5.5 LighTouch Medical, Inc. Company Overview 19
5.5.1 LighTouch Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
5.6 POPS! Diabetes Care Inc Company Overview 21
5.6.1 POPS! Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 21
6 Traditional Glucose Meters- Recent Developments 23
6.1 Mar 27, 2017: DarioHealth Launches Insurance Coverage Option for U.S. Consumers 23
6.2 Mar 22, 2017: DarioHealth Reports Fourth Quarter and Year End 2016 Results 23
6.3 Mar 14, 2017: PositiveID’s E-N-G Mobile Systems’ 2017 Bookings Through February Total $1.7 Million, Up More than 200% from Prior Quarter 25
6.4 Mar 02, 2017: DarioHealth Strengthens Board of Directors with Two Additional Appointments 25
6.5 Feb 21, 2017: PositiveID Announces 2016 Highlights 26
6.6 Jan 23, 2017: DarioHealth Accelerates US Device Sales and Consumable Strips Growth in Fourth Quarter 27
6.7 Jan 09, 2017: DarioHealth Raises USD5.1 Million in Venture Financing 27
6.8 Jan 05, 2017: Intuity Medical Raises Additional USD15 Million in Series 3 Financing 27
6.9 Dec 06, 2016: One Drop Announces FDA Clearance And One Drop | Premium Launches In US, UK, And EU 27
6.10 Dec 05, 2016: Ascensia Selects Agnitio's Rainmaker Solution 29
6.11 Dec 01, 2016: BioTelemetry Acquires Telcare Medical Supply and Associated Assets 29
6.12 Nov 21, 2016: PositiveID Reports Revenue of $4.6 Million for First Nine Months of 2016, Up 70% from $2.7 Million for First Nine Months of 2015 30
6.13 Nov 05, 2016: POPS! Diabetes is key sponsor of Elite 8 30
6.14 Nov 03, 2016: RSP Systems awarded EUR2.4 million grant for GlucoBeam by the European Union's Horizon 2020 framework 31
6.15 Oct 25, 2016: DarioHealth Reports Successful Traction for Dario 31
6.16 Oct 25, 2016: Intuity Medical Raises USD40 Million in Series 3 Financing 32
6.17 Oct 19, 2016: PositiveID to Present at RedChip's Global Online Growth Conference on October 20th 32
6.18 Sep 27, 2016: PositiveID Announces Highlights for Third Quarter 2016 32
6.19 Sep 15, 2016: PositiveID to Present at the 2016 Aegis Growth Conference on September 22nd 33
6.20 Aug 15, 2016: PositiveID Reports Q2 2016 Revenue of $1.8 Million, Up from $51 Thousand in Q2 2015 34
6.21 Aug 11, 2016: DarioHealth Reports Second Quarter 2016 Results 35
6.22 Jul 28, 2016: DarioHealth is Now Direct-to-Consumer in Australia 36
6.23 Jul 27, 2016: LabStyle Innovations Now DarioHealth 37
6.24 Jul 21, 2016: LabStyle Innovations Executes Distribution Partnership with GEMCO Medical 38
6.25 Jul 19, 2016: LabStyle Reports 100%-Plus Monthly Growth in U.S. Users Since Launch 38
6.26 Jul 12, 2016: PositiveID Announces Highlights for First Half of 2016 39
6.27 Jul 11, 2016: LabStyle Innovations Joins College Diabetes Network (CDN) 40
6.28 Jul 08, 2016: RSP Systems Raises USD5 Million in Series A Financing 40
6.29 Jul 01, 2016: Top Tech: A blood glucose device wins an ADA award for tech innovation 41
6.30 Jun 21, 2016: PositiveID’s Mobile Lab Business Completed 80 Projects in the First Half of 2016 42
6.31 May 31, 2016: PositiveID Adds Benedikt von Braunmuhl to its Board of Advisors 42
6.32 May 26, 2016: PositiveID to Present at the 2016 Marcum MicroCap Conference on June 1st 43
6.33 May 17, 2016: PositiveID Reports Q1 2016 Revenue of $1.7 Million, Up from $0.1M in Q1 2015 43
6.34 May 11, 2016: LabStyle Innovations Reports Q1 2016 Results 44
6.35 May 05, 2016: LabStyle Innovations Granted Key Patent in Europe Relating to the Dario Diabetes Management Tool 45
6.36 Apr 26, 2016: Intuity Medical Receives FDA Clearance to Market POGO Automatic Blood Glucose Monitoring System 45
7 Appendix 47
7.1 Methodology 47
7.2 About GlobalData 50
7.3 Contact Us 50
7.4 Disclaimer 50
1.1 List of Tables
Table 1: Traditional Glucose Meters - Pipeline Products by Stage of Development 6
Table 2: Traditional Glucose Meters - Pipeline Products by Territory 7
Table 3: Traditional Glucose Meters - Pipeline Products by Regulatory Path 8
Table 4: Traditional Glucose Meters - Pipeline Products by Estimated Approval Date 9
Table 5: Traditional Glucose Meters - Ongoing Clinical Trials 10
Table 6: Traditional Glucose Meters Companies - Pipeline Products by Stage of Development 11
Table 7: Traditional Glucose Meters - Pipeline Products by Stage of Development 12
Table 8: Integrity Applications Ltd Pipeline Products & Ongoing Clinical Trials Overview 13
Table 9: GlucoTrack - DF-D - Product Status 13
Table 10: GlucoTrack - DF-D - Product Description 14
Table 11: GlucoTrack - DF-I - Product Status 14
Table 12: GlucoTrack - DF-I - Product Description 14
Table 13: GlucoTrack - DF-N - Product Status 15
Table 14: GlucoTrack - DF-N - Product Description 15
Table 15: IntelliDx Inc Pipeline Products & Ongoing Clinical Trials Overview 16
Table 16: Optimus - Product Status 16
Table 17: Optimus - Product Description 16
Table 18: Intuity Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 17
Table 19: POGO Automatic Blood Glucose Monitoring System - Product Status 17
Table 20: POGO Automatic Blood Glucose Monitoring System - Product Description 17
Table 21: LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview 18
Table 22: OneTouch Verio Blood Glucose System - Version 3 - Product Status 18
Table 23: OneTouch Verio Blood Glucose System - Version 3 - Product Description 18
Table 24: LighTouch Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19
Table 25: LighTouch Glucose Monitor - Product Status 19
Table 26: LighTouch Glucose Monitor - Product Description 19
Table 27: LighTouch Medical, Inc. - Ongoing Clinical Trials Overview 20
Table 28: LighTouch Glucose Monitor - In Vivo Raman Spectroscopy (IVRS) of Human Fingertip Capillary Beds 20
Table 29: POPS! Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 21
Table 30: Pediatric POPS! SmartMeter - Product Status 21
Table 31: Pediatric POPS! SmartMeter - Product Description 21
Table 32: POPS! SmartMeter - Product Status 21
Table 33: POPS! SmartMeter - Product Description 22
Table 34: Glossary 49
1.2 List of Figures
Figure 1: Traditional Glucose Meters - Pipeline Products by Stage of Development 6
Figure 2: Traditional Glucose Meters - Pipeline Products by Territory 7
Figure 3: Traditional Glucose Meters - Pipeline Products by Regulatory Path 8
Figure 4: Traditional Glucose Meters - Pipeline Products by Estimated Approval Date 9
Figure 5: Traditional Glucose Meters - Ongoing Clinical Trials 10
